ACTRN 12623000640606 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12623001338651 Brief Summary The purpose of this trial is to assess…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design outpatient…
Read more arrow_forwardNCT 05694936 Brief Summary The aim of this study is to determine…
Read more arrow_forwardNCT 06907641 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardACTRN 12618001480279 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardACTRN 12624001345572 Brief Summary This study will investigate the effect Atezolizumab (Anti-PD-L1…
Read more arrow_forwardNCT 05911295 Brief Summary This study will enroll participants with urothelial cancer…
Read more arrow_forwardNCT 07110584 Brief Summary This study is designed to characterize the safety,…
Read more arrow_forward